To be the foremost partner for clients, delivering comprehensive Clinical Contract Research Services with expertise, efficiency and integrity.
How this is achieved:
Expertise: role specific internal and external training, regulation awareness updates, company-wide project feedback
Efficiency: understanding customers’ needs, recognizing market demands, management of change, identifying new business opportunities, commitment, flexibility, communication, teamwork, continuous performance improvement, business legislation review, customer feedback and complaints process;
Integrity: maintaining honour and mutual respect in external and internal relationships, personal responsibility;
TCTC senior management is committed to this policy and will provide:
Strong Leadership: Passion, commitment, vision and communication
Development: encourage talent, create opportunities for people to learn, training
Resources: the tools and the people for the job
Rewards: Financial, Personal Development and Career
As one of the fastest growing CROs globally, TCTC Group™ has ambitious growth plans which relate to servicing its clients’ businesses more efficiently. Our Global Head Office is in the UK (Knutsford, Cheshire) with a Specialist CNS Office in Scotland (Stirling).
The North American business, The CLINICAL TRIAL Company (USA) Inc., is headquartered in San Mateo, California and The CLINICAL TRIAL Company (Canada) is located in Montréal. The CLINICAL TRIAL Company (ANZ) Pty Ltd has its head office in Melbourne. The CLINICAL TRIAL Company (Asia) Pte. Ltd has its head office in Singapore.
TCTC operates throughout North America, Central and South America, The European Union, Eastern Europe, Asia, Africa, Australasia and New Zealand. In the past year TCTC has been active with clinical trials and services in the following countries UK, Australia, The Netherlands, Germany, Sweden, Belgium, Denmark, Poland, France, Spain, Bulgaria, Ireland, Greece, Italy, Romania, Switzerland, Turkey, Macedonia, Russia, Hungary, Ukraine, Mexico, US, Canada, Australia, India, China, Singapore, Thailand, Taiwan, Hong Kong, Philippines, South Korea, Brazil, Argentina, Malaysia, Puerto Rico, South Africa and Burkina Faso.
TCTC Group™ provides full-service clinical studies and stand-alone clinical trial, regulatory, quality, personnel and training services to companies throughout the world.
TCTC Group™ specializes in products without a classical road map to approval. This includes Advanced Therapies such as Cell and Gene Therapy. TCTC Group has a wealth of experience with ATMP's, Orphan Drugs and drug-device combinations.
TCTC Group™ also has a translation team who cover all the major languages and other languages such as Arabic, Chinese and the local languages used in India.
Within TCTC Group™ there is a strong independent Quality Assurance team who have obtained ISO 9001:2015 registration and developed a Quality Management System which, in their last MHRA statutory GCP Inspection, resulted in zero Critical and Major Findings.